1.80
Finanzdaten der Arcadia Biosciences Inc-Aktie (RKDA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.302
|
- | 1.20 | 1.216 | 1.537 |
| Cost Of Revenue |
0.884
|
- | 0.682 | 0.827 | 1.032 |
| Gross Profit |
0.418
|
- | 0.518 | 0.389 | 0.505 |
|
|
1.57
|
- | -0.012 | 2.668 | 2.265 |
| Benefits Costs and Expenses |
0.446
|
- | -1.399 | 5.245 | 2.719 |
| Costs And Expenses |
2.454
|
- | 0.67 | 3.495 | 3.297 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
-1.152
|
- | 0.53 | -2.279 | -1.76 |
| Net Interest Income/Expense |
0.007
|
- | 0.207 | 0.354 | 0.233 |
| Interest Income/Expense After Provision For Losses |
0.007
|
- | 0.207 | 0.354 | 0.233 |
| Income/Loss From Continuing Operations Before Tax |
119.20%
0.856
|
-4.458 | 2.599 | -4.029 | -1.182 |
| Income/Loss From Continuing Operations After Tax |
119.20%
0.856
|
-4.458 | 2.599 | -4.037 | -1.182 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | - |
|
|
119.20%
0.856
|
-4.458 | 2.599 | -4.064 | -1.612 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.3672
|
- | 1.3661 | 0.000549 | 1.3638 |
| Diluted Average Shares |
1.3719
|
- | 1.3662 | 0.000549 | 1.3638 |
| Basic Earnings Per Share |
0.63
|
- | 1.90 | -2.99 | -1.18 |
| Diluted Earnings Per Share |
0.62
|
- | 1.90 | -2.99 | -1.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):